Has Lydia Stearns received payments from drug or device companies?

Yes. Drug and device makers reported $9,768 in general payments to Lydia Stearns across 525 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lydia Stearns did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lydia Stearns come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lydia Stearns

Physician Assistant · Savannah, GANPI 1174046635

Payments from drug & device makers

$9,768in general payments, 2019–2025

Across 525 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Otsuka America Pharmaceutical, Inc.$945
Axsome Therapeutics, Inc.$816
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$738
Teva Pharmaceuticals USA, Inc.$612
Takeda Pharmaceuticals U.S.A., Inc.$585
plus $4K from 24 others

What the payments were for

Food & beverage$9,65199%
Education$1171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	141	$1,785
Otsuka America Pharmaceutical, Inc.	42	$945
Axsome Therapeutics, Inc.	31	$816
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	31	$738
Teva Pharmaceuticals USA, Inc.	44	$612
Takeda Pharmaceuticals U.S.A., Inc.	34	$585
Corium, LLC	35	$578
Johnson & Johnson	26	$538
Supernus Pharmaceuticals, Inc.	12	$481
Alkermes, Inc.	24	$424
Neurocrine Biosciences, Inc.	14	$286
Tris Pharma Inc	12	$253
Indivior Inc.	9	$199
Neos Therapeutics, LP	10	$186
Lundbeck LLC	8	$175
Ironshore Pharmaceuticals Inc.	6	$129
Sunovion Pharmaceuticals Inc.	7	$126
Adlon Therapeutics L.p.	6	$125
E.r. Squibb & Sons, L.L.C.	1	$124
Jazz Pharmaceuticals Inc.	4	$101
Eisai Inc.	6	$98
Avanir Pharmaceuticals, Inc.	5	$96
Bausch Health US, LLC	4	$82
Braeburn Inc.	4	$82
Noven Therapeutics, LLC	3	$68
Harmony Biosciences LLC	2	$59
Vanda Pharmaceuticals Inc.	1	$24
USWM, LLC	1	$22
OWP Pharmaceuticals, Inc.	1	$20
Vivus LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,768 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Austedo XrDeutetrabenazine	36	$213,678
Invega SustennaPaliperidone Palmitate	13	$48,848
RexultiBrexpiprazole	12	$20,283
TrintellixVortioxetine Hydrobromide	18	$17,292
Lurasidone Hcl	14	$5,455
Duloxetine Hcl	85	$3,809
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	47	$2,896
Aripiprazole	47	$2,684
Bupropion XlBupropion Hcl	69	$1,675
Fluvoxamine Maleate	28	$1,494
Clonazepam	154	$1,412
Escitalopram Oxalate	42	$961
Trazodone Hcl	70	$935
Fluoxetine Hcl	72	$900
Modafinil	24	$838

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr	$612	$213,67836 claims
Johnson & JohnsonInvega Sustenna	$538	$48,84813 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$945	$20,28312 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix	$585	$17,29218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Savannah

Jody HannahSavannah$59K
Scott SchnaibleSavannah$15K
Edith UtleySavannah$15K
Allison AndrewsSavannah$14K
Douglas DiruggieroCartersville$1.3M
Jennifer CobbsAtlanta$1M
A BrunnerStockbridge$1M
Joseph LangshawCalhoun$887K
Alison MoeAtlanta$410K
Maggie SchreckAtlanta$389K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →